Gallic acid attenuates metastatic potential of human colorectal cancer cells through the miR ‐1247‐3p‐modulated integrin/ FAK axis
Environmental Toxicology · 2024
DOI: 10.1002/tox.24087 ↗Kurz gefasst
Fachartikel in der Zeitschrift Environmental Toxicology, 2024. Verfasst von Chi-Chou Huang und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Colorectal Surgery, Chung Shan Medical University Hospital, Taichung, Taiwan. Hauptthemen laut MEDLINE: MicroRNAs, Colorectal Neoplasms. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 45 Literaturangaben. Gefördert von: National Science and Technology Council.
Abstract (Originalsprache)
Colorectal cancer (CRC) exhibits highly metastatic potential even in the early stages of tumor progression. Gallic acid (GA), a common phenolic compound in plants, is known to possess potent antioxidant and anticancer activities, thereby inducing cell death or cell cycle arrest. However, whether GA reduces the invasiveness of CRC cells without inducing cell death remains unclear. Herein, we aimed to investigate the antimetastatic activity of low‐dose GA on CRC cells and determine its underlying mechanism. Cell viability and tumorigenicity were analyzed by MTS, cell adhesion, and colony formation assay. Invasiveness was demonstrated using migration and invasion assays. Changes in protein phosphorylation and expression were assessed by Western blot. The involvement of microRNAs was validated by microarray analysis and anti‐miR antagonist. Our findings showed that lower dose of GA (≤100 μM) did not affect cell viability but reduced the capabilities of colony formation, cell adhesion, and invasiveness in CRC cells. Cellularly, GA downregulated the cellular level of integrin αV/β3, talin‐1, and tensin and diminished the phosphorylated FAK, paxillin, Src, and AKT in DLD‐1 cells. Microarray results revealed that GA increased miR‐1247‐3p expression, and pretreatment of anti‐miR antagonist against miR‐1247‐3p restored the GA‐reduced integrin αV/β3 and the GA‐inhibited paxillin activation in DLD‐1 cells. Consistently, the in vivo xenograft model showed that GA administration inhibited tumor growth and liver metastasis derived from DLD‐1 cells. Collectively, our findings indicated that GA inhibited the metastatic capabilities of CRC cells, which may result from the suppression of integrin/FAK axis mediated by miR1247‐3p.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Colorectal Surgery, Chung Shan Medical University Hospital, Taichung, Taiwan.
- School of Medicine, Chung Shan Medical University, Taichung, Taiwan.
- Division of Gastroenterology and Hepatology, Department of Internal Medicine, Chung Shan Medical University Hospital, Taichung, Taiwan.
- Division of Cardiovascular Surgery, Surgical Department, Chung Shan Medical University Hospital, Taichung, Taiwan.
- Department of Pathology, Chung Shan Medical University Hospital, Taichung, Taiwan.
- Department of Pathology, School of Medicine, Chung Shan Medical University, Taichung, Taiwan.
ORCID-Profile: Shao-Hsuan Kao
Förderung
- National Science and Technology Council
Zitieren
APA
Huang, C. C., Tsai, M. C., Wu, Y. L., Lee, Y. J., Yen, A. T., Wang, C. J., & Kao, S. H. (2024). Gallic acid attenuates metastatic potential of human colorectal cancer cells through the miR ‐1247‐3p‐modulated integrin/ FAK axis. Environmental Toxicology. https://doi.org/10.1002/tox.24087
Vancouver
Huang CC, Tsai MC, Wu YL, Lee YJ, Yen AT, Wang CJ, et al. Gallic acid attenuates metastatic potential of human colorectal cancer cells through the miR ‐1247‐3p‐modulated integrin/ FAK axis. Environmental Toxicology. 2024. doi:10.1002/tox.24087
BibTeX
@article{Huang2024,
author = {Huang, Chi-Chou and Tsai, Ming-Chang and Wu, Yi-Liang and Lee, Yi-Ju and Yen, An-Ting and Wang, Chau-Jong and Kao, Shao-Hsuan},
title = {Gallic acid attenuates metastatic potential of human colorectal cancer cells through the miR ‐1247‐3p‐modulated integrin/ FAK axis},
journal = {Environmental Toxicology},
year = {2024},
doi = {10.1002/tox.24087}
}
EUVIMED